← Back to Search

Online Counseling for Chronic Pain and Alcohol Use

N/A
Waitlist Available
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Engaged in HIV care
Heavy drinking defined as more than 7/14 drinks per week for women/men or by a single episode of 4/5 (women/men)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will test a new way to help HIV patients who drink too much and have chronic pain, by talking to them over the internet.

Who is the study for?
This trial is for HIV-care patients who drink heavily (more than 7/14 drinks per week for women/men) and have chronic non-cancer pain lasting at least 3 months. It's not suitable for those with upcoming surgeries, on short-term psychoactive meds, or with bipolar disorder, schizophrenia, suicidal intent, a history of severe alcohol withdrawal symptoms, or current treatment for pain or alcohol use.Check my eligibility
What is being tested?
The study tests an integrated behavioral approach to reduce heavy drinking and chronic pain via internet-based videoconferencing. Participants will either continue their usual care or receive the Motivational and Cognitive-Behavioral Management program designed specifically for Alcohol and Pain (MCBMAP).See study design
What are the potential side effects?
Since this is a behavioral intervention involving motivational talks and cognitive-behavioral therapy through video calls rather than medication, typical drug side effects are not expected. However, participants may experience emotional discomfort discussing sensitive topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Currently receiving treatment for HIV.
Select...
You drink more than 7 drinks per week (for women) or 14 drinks per week (for men), or you have a single episode of drinking 4 drinks (for women) or 5 drinks (for men) at one time.
Select...
You have had moderate or severe non-cancer pain for at least three months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol Time Line Follow-Back (30) - Average Drinks per Week
Alcohol Time Line Follow-Back (30)- Heavy Drinking Episodes
Brief Pain Inventory - Pain Interference
+1 more
Secondary outcome measures
Goal Systems Assessment Battery-Alcohol
Goal Systems Assessment Battery-Pain
Short Inventory of Alcohol Problems-Revised

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Videoconferencing Intervention for Heavy Drinking and Chronic Pain
Group II: ControlActive Control1 Intervention
Treatment as Usual
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP)
2020
N/A
~50

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
113 Previous Clinical Trials
12,112 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
797 Previous Clinical Trials
1,361,437 Total Patients Enrolled

Media Library

Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP) Clinical Trial Eligibility Overview. Trial Name: NCT04441593 — N/A
Alcohol Drinking and Chronic Pain Intervention Research Study Groups: Control, Intervention
Alcohol Drinking and Chronic Pain Intervention Clinical Trial 2023: Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP) Highlights & Side Effects. Trial Name: NCT04441593 — N/A
Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04441593 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Apr 2025